BLRX - BioLineRx Ltd.
2.65
-0.060 -2.264%
Share volume: 9,538
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.71
-0.06
-0.02%
Summary score
5%
Profitability
0%
Dept financing
7%
Liquidity
38%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.02%
Return on assets
-11.73%
Return on sales
0%
Return on invested capital
-121.66%
Total debt ratio
19.26%
Debt ratio change over timeo
0%
Current Ratio
7.18%
Quick Ratio
0%
Cash Position Ratio
0.83%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.06%
Return on assets
-13.57%
Return on sales
0%
Return on invested capital
-45.42%
Total debt ratio
35.33%
Debt ratio change over timeo
0%
Current Ratio
2.9%
Quick Ratio
0%
Cash Position Ratio
0.48%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-23.35%
Return on assets
-14.53%
Return on sales
0%
Return on invested capital
-50.18%
Total debt ratio
39.56%
Debt ratio change over time
0%
Current Ratio
1.88%
Quick Ratio
0%
Cash Position Ratio
0.43%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BLRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -14.02% | 16.32% | 4.62% | -0.95% |
| Return on assets | -11.73% | 3.37% | 3.4% | 3.77% |
| Return on sales | 0% | 23.81% | 26.22% | 33.63% |
| Return on invested capital | -121.66% | 4.94% | 4.34% | 5.38% |
| Profitability | 0% | 88% | 69% | 75% |
| Total debt ratio | 19.26% | 76.12% | 57.49% | 101.27% |
| Debt ratio change over time | 0% | 0% | 10.95% | 76.91% |
| Dept financing | 5% | 19% | 18% | 50% |
| Current Ratio | 2.9% | 1.14% | 1.29% | 2.09% |
| Quick Ratio | 0% | 0.88% | 1.02% | 1.98% |
| Cash Position Ratio | 0.48% | 0.17% | 0.52% | 1.5% |
| Liquididy | 50% | 33% | 48% | 54% |
| Short-term ratios | BLRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -19.06% | 47.37% | 7.11% | -26.47% |
| Return on assets | -13.57% | 4% | 3.45% | 4.51% |
| Return on sales | 0% | 27.25% | 25.98% | 37.94% |
| Return on invested capital | -45.42% | 9.88% | 5.48% | 9.05% |
| Profitability | 0% | 90% | 54% | 73% |
| Total debt ratio | 35.33% | 92.44% | 61.53% | 111.53% |
| Debt ratio change over time | 0% | 0% | 14.12% | 17.59% |
| Dept financing | 8% | 21% | 34% | 50% |
| Current Ratio | 2.9% | 1.14% | 1.29% | 2.09% |
| Quick Ratio | 0% | 0.88% | 1.02% | 1.98% |
| Cash Position Ratio | 0.48% | 0.17% | 0.52% | 1.5% |
| Liquididy | 33% | 24% | 33% | 68% |